4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001415889-24-018417
CFO, EVP & TREASURER sold 3,596 shares at an average $40.93 ($147,169)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PETERS WILLIAM J CFO, EVP & TREASURER | 2024-06-27 | Sale 10b5-1 | −2,961 | $40.85 | $120,947 | 94,738 | D |
| PETERS WILLIAM J CFO, EVP & TREASURER | 2024-06-27 | Sale 10b5-1 | −635 | $41.29 | $26,222 | 94,103 | D |
| Open-market sales · 3,596 sh · avg $40.93 · $147,169 | |||||||
Loading xslF345X05/form4-06282024_080649.xml…